Pharma Journalist 8969 posts 0 comments

Pfizer Inc. announced results from a Phase 4 study evaluating the efficacy and safety of CHANTIX/CHAMPIX (varenicline) for smoking cessation in nicotine dependent adolescents 12-19…
Read More...

Flex Pharma announced positive topline data for FLX-787 from its exploratory Phase 2 trial in MS patients with frequent muscle cramps/spasms and spasticity. “MS patients frequently…
Read More...

SetPoint Medical announced that it has launched a pilot trial for patients with drug refractory rheumatoid arthritis (RA) in the U.S. The multi-center study, “A Randomized Controlled…
Read More...

Acorda Therapeutics announced that it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for INBRIJA. Acorda is seeking marketing approval…
Read More...

FORMA Therapeutics and Arpeggio Biosciences announced a collaboration to utilize Arpeggio Biosciences’ proprietary technology to supplement FORMA’s analysis of the biological effects of…
Read More...

PharmaCyte Biotech, Inc. announced that it has filed a U.S. patent application with the United States Patent and Trademark Office (USPTO) to protect its therapy to treat cancerous…
Read More...

3P Biopharmaceuticals and Intervacc complete manufacturing agreement for new vaccine against equine strangles 3P Biopharmaceuticals and the Swedish company Intervacc have now…
Read More...

Astellas Pharma and Seattle Genetics announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to enfortumab vedotin, an antibody-drug…
Read More...

Shire plc and NanoMedSyn announced that the companies have entered into a preclinical research collaboration to evaluate a potential ERT using NanoMedSyn's proprietary synthetic…
Read More...

Teva Pharmaceutical Industries Ltd., announced the launch of a generic version of ALOXI®1 (palonosetron HCI) injection, 0.25 mg/5 mL, in the United States. Palonosetron hydrochloride…
Read More...